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A B S T R A C T
Reactive oxygen species and lipid peroxidation products are not only cytotoxic but may also modulate signal trans-
duction in cells. Accordingly, antioxidants may be considered as modifiers of cellular redox signaling. Therefore, the ef-
fects of two novel synthetic antioxidants, analogues of 1,4-dihydropyridine derivatives, cerebrocrast and Z41-74 were
analysed in vitro on human osteosarcoma cell line HOS, the growth of which can be modulated by lipid peroxidation.
The cells were pretreated with either cerebrocrast or Z41-74 and afterwards exposed to mild, copper induced lipid per-
oxidation or to 4-hydroxynonenal (HNE), the end product of lipid peroxidation. The results obtained have shown that
both antioxidants exert growth modulating effects interfering with the lipid peroxidation. Namely, cells treated with an-
tioxidants showed increased metabolic rate and cell growth, thereby attenuating the effects of lipid peroxidation. Such
biomodulating effects of cerebrocrast and Z41-74 resembled growth modulating effects of HNE, suggesting that the anti-
oxidants could eventually promote cellular adaptation to oxidative stress interacting with redox signaling and hydroxy-
nonenal HNE-signal transduction pathways. This may be of particular relevance for better understanding the beneficial
role of hydroxynonenal HNE in cell growth control. Therefore, cerebrocrast and Z41-74 could be convenient to study fur-
ther oxidative homeostasis involving lipid peroxidation.
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Introduction
Oxidative stress is a process where reactive oxygen
species (ROS) are formed in excess and the steady-state
equilibrium between formation and elimination of ROS
is disturbed1. Excessive production of ROS, often caused
by transition metals (copper and iron) in the vicinity of
cellular membranes induces lipid peroxidation, having as
a result production of reactive aldehydes, namely malon-
dialdehyde (MDA), 4-hydroxynonenal (HNE), and acro-
lein2. One of the most intensively studied aldehydes is
HNE, a major lipid peroxidation product of w-6 polyun-
saturated fatty acids (e.g. linoleic and arachidonic acid),
nowadays considered as a major bioactive marker of lipid
peroxidation3.
Depending on its concentration, HNE can be consid-
ered as cell growth modulator under physiological con-
centrations and as inhibitor of cell growth under high,
pathological concentrations4. Usually, 1 mM HNE is re-
ferred as a physiological concentration of the aldehyde,
10 mM as a supraphysiological, while higher values are
pathological with 50 mM considered as LD50 for majority
of the cell types treated in vitro2. Exposure to pathologi-
cal concentrations of HNE causes strong inhibition of se-
veral cellular functions; mitochondrial respiration, DNA,
RNA and protein synthesis2,5. Recently, it has been dem-
onstrated that HNE acts as a signaling molecule in
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pathological but also in physiological conditions3,6. The
presence of physiological concentrations of HNE (1 mM)
could depend on the presence of serum factors, but not
serum albumin which is known to couple with HNE thus
decreasing the effects of the aldehyde7–9. HNE can induce
in vitro proliferation of malignant cells, such as HeLa, as
well as of non-malignant cells, like aortic smooth muscle
cells, interfering with the activity of cytokines thereby
acting as a growth-regulating factor5,10. Hence, HNE
modulates also cell proliferation of human osteosarcoma
cells (HOS cell line), which often show functional differ-
entiation in vitro into osteoblasts and are considered as
convenient model to study human bone cells11.
While these biomedical activities are not commonly
well known, oxidative stress is usually considered as
pathological background of numerous diseases. Conse-
quently, antioxidants are often considered as substances
that counteract harmful effects of free radicals thereby
preventing the onset of various diseases. However, recent
concepts of oxidative homeostasis suggest also beneficial
effects of mild oxidative stress and consider antioxidants
as biological modifiers of oxidative homeostasis12,13. Re-
cently, many new antioxidants have been synthesized,
which possess potent free radical scavenging capacities.
However, solubility, permeability, stability, and pharma-
cokinetic parameters like absorption, distribution, me-
tabolism and excretion are the important properties that
affect the dose efficiency of antioxidants14. Therefore,
synthetic antioxidants should be tested in vitro and in
vivo before being considered for human use, as in case of
other potential medical remedies. In the present study
we tested in vitro effects of two derivatives of 1,4-dihy-
dropyridine using human osteosarcoma cell line (HOS),
which is known to be sensitive not only to the cytotoxic
but also to the growth modulating effects of HNE acting
as mediator of oxidative homeostasis and of lipid pero-
xidation15.
Z41-74 is an N,N,N-trimethylammonium analogue of
the 1,4-dihydropyridine compound described by Urtti et
al.16, while cerebrocrast (CER) exerts broad spectrum of
protective properties (neuroprotective, memory-enhanc-
ing, anti-ischemic, cardioprotective, anti-diabetic, anti-
inflammatory)17,18. This antioxidant prevents cell death,
free radical production and decrease in mitochondrial
membrane potential in MPP+ neurotoxicity model (cere-
bellar granule cells)19. Oxygen-glucose deprivation cell
damage is also prevented by cerebrocrast20. Cerebrocrast
has an anti-inflammatory effect21, and was shown to pro-
tect the immune system in streptozocin-induced diabetic
rats from streptozocin toxicity, preventing thymus and
lymph node mass loss, as well as pancreatic beta cell
damage22.
Aiming to see if CER and/or Z41-74 could be involved
in growth modulation under mild oxidative stress and
lipid peroxidation, HOS cells were cultured in the pres-
ence of CER or Z41-74 and were exposed to copper-in-




Tested compounds denoted cerebrocrast 4-(2-difluoro-
methoxyphenyl)-2,6-dimethyl-3,5-bis[(2-propyloxy)ethoxy-
carbonyl]-1,4-dihydropyridine (Mw=511.6) and N,N'-[3,
5-bis-methyloxycarbonyl-4-phenyl-1,4-dihydropyridin-2,6-
diyl]dimethylene]bis-N,N,N-trimethylammonium dibromi-
de (Z41-74) (Mw=577.37) were synthesized at the Lat-
vian Institute of Organic Synthesis. All of these com-
pounds are studied as potential antioxidants and accord-
ing to high performance liquid chromatography (HPLC)
data are at least of 98% purity.
Cell culture
The human osteosarcoma (HOS) cell line was obtai-
ned from the American Type Culture Collection (ATCC).
Cells were maintained in DMEM with 10% (v/v) FCS
(Sigma, USA) in an incubator (Heraeus, Germany) at 37
°C, with a humid air atmosphere containing 5% CO2. The
cells of semiconfluent cultures were detached with 0.25%
w/v trypsin solution and viable cells were counted on
Bürker-Türk hemocytometer upon trypan blue exclusion.
4-Hydroxynonenal
HNE was obtained from Karl-Franzens University in
Graz, Austria in the form of HNE-DMA (dimethylacetal)
1 mg/mL preserved in chloroform and kept at –20 °C. Be-
fore use HNE was activated as described before3.
3H-thymidine (3H-TdR) incorporation assay
HOS cells were seeded in 96 microwell plates at den-
sity of 2´104 per well, and were allowed 24 h to adhere.
After adhering period, cells were treated with CER and
Z41-74 at concentrations 0.1, 1 and 10 mM for 1h, when
CuSO4 was added at concentrations of 20, 50 and 100
mM. After 48h, 3H-thymidine (1 mCi/well, Amersham,
USA) was added to each well and left for additional 24h,
as described before24.
Using the above mentioned concentration range of
CuSO4 allowed induction of moderate lipid peroxidation
and the insight into the growth modulating activities of
the antioxidants under such a mild oxidative stress.
MTT assay
HOS cells were seeded in 96 microwell plates at den-
sity of 2´104 per well. After allowing cells to adhere for 24
h, media were removed and cells were treated with CER
and Z41-74 at concentrations 0.1, 1 and 10 mM for 1h,
when HNE was added in concentrations of 1, 10 and 100
mM. After 24h incubation period, MTT assay (EZ4U,
Biomedica Austria) was done as described before, since it
reflects well mitochondrial metabolic activity of the cells
thus reflecting their growth23.
Using the above mentioned concentration range of
HNE allowed the insight into the growth modulating ac-
tivities of the antioxidants under mild oxidative stress.
T. Lovakovi} et al.: Oxidative Stress, Antioxidants and the Cell Growth, Coll. Antropol. 35 (2011) 1: 137–141
138
Statistics
All assays were carried out in quadruplicates. Signifi-
cance was calculated according to the Student’s t-test.
The values of p<0.05 were considered as statistically sig-
nificant.
Results
The effects of CER and Z41-74 on the
CuSO4-affected cell proliferation
The influence of antioxidant compounds CER and
Z41-74 in combination with CuSO4 as oxidant is shown
on Figure 1. Oxidant CuSO4 alone significantly decreas-
ed cell proliferation in a concentration-dependent man-
ner (p<0.05), with maximum inhibition of 30% observed
after treatment with the highest concentration of CuSO4
used (100 mM). CER alone only at the concentration of
10 mM caused significant increase in cell proliferation
(p<0.05). On the other hand, Z41-74 alone significantly
increased cell proliferation in concentrations of 0.1 and
1mM respectively (p<0.05). The highest concentration of
Z41-74 used (10 mM), did not enhance the proliferation
of the cells (p>0.05).
Negative effects of CuSO4 on cell proliferation were
reduced in a concentration-dependent manner by CER at
all concentrations used (p<0.05). At the lowest CuSO4
concentration used, negative effect of the stressor were
completely abolished by CER and even overwhelmed to
level of significant stimulation of cell proliferation. De-
crease in cell proliferation caused by the highest CuSO4
concentration was suppressed by all concentrations of
CER used (p<0.05). Accordingly, neither 20 nor 50 mM
CuSO4 did significantly affect the stimulation of cell pro-
liferation caused by CER.
Z41-74 was more effective than CER at the lowest
dose (0.1 mM), while opposite was observed for the high-
est concentration of the antioxidants (10 mM), in which
case CER was more efficient than Z41-74.
The effects of CER and Z41-74 on the
HNE-affected cell growth
The effects of HNE and tested compounds, CER and
Z41-74, on the growth of HOS cells are shown on Figure
2. HNE enhanced cell growth at concentrations of 1 and
10 mM, while at concentration of 100 mM HNE signifi-
cantly (p<0.05) inhibited the cell growth. Both com-
pounds, CER and Z41-74, significantly increased cell
growth in all used concentrations (0.1, 1 and 10 mM), al-
though CER was shown to be more effective.
CER, in combination with 1 and 10 mM HNE showed
modulation of cell growth. These combinations of CER
and HNE significantly increased cell growth in compari-
son to cells treated with the same concentrations of HNE
but without CER (p<0.05). Still, the stimulating effects
of CER and HNE did not reach the level of stimulation by
CER alone. At 100 mM HNE, CER was not able to dimin-
ish the inhibition of cell growth caused by HNE.
Z41-74 showed different reaction pattern than CER.
Namely, Z41-74 alone increased cell growth at the same
level regardless of concentration used. In combination
with 1 and with 10 mM HNE the cell growth was addi-
tionally increased in the presence of 0.1 or 1 mM Z41-74
(in both cases, p<0.05). The highest concentration of
Z41-74 used (10 mM) only in combination with 10 mM
HNE significantly increased cell growth (p<0.05). Simi-
lar to CER, Z41-74 also did not modify the growth inhibi-
tion of HOS cells treated with 100 mM HNE.
Therefore, major difference between the two antioxi-
dants was observed in respect to the interference with
HNE because CER showed better stimulatory effect when
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Fig. 1. Influence of novel compounds CER and Z41-74 on HOS
cell proliferation – 3H-TdR incorporation assay. Cells were trea-
ted with different concentrations of CuSO4 alone (denoted as ctrl
on Figure), or in combination with either cerebrocrast (CER) or
Z41-74. Results were expressed as mean±SD in percentage of un-
treated cells (cells cultured without any stressor or compound tes-
ted). *significantly different compared to untreated cells (without
CuSO4 and without antioxidant) + significantly different com-























Fig. 2. Influence of novel compounds CER or Z41-74 in combina-
tion with HNE on cell viability determined by MTT assay. Cells
were treated with different concentrations of HNE alone (denoted
as ctrl on Figure), or in combination with either cerebrocrast (CER)
or Z41-74. Results were expressed as mean ± SD in percentage of
untreated cells (cells cultured without any stressor or compound
tested). * significantly different compared to untreated cells (with-
out HNE and without antioxidant) + significantly different com-
pared to the same HNE concentration but without antioxidant.
added alone whereas Z41-74 showed better growth stim-
ulation when combined with HNE.
Discussion and Conclusion
Oxidative stress and lipid peroxidation are considered
usually only as negative factors of cell growth regulation.
However, recent findings provide better insight into the
role of oxidative stress in physiological processes intro-
ducing the term of oxidative homeostasis12. Namely, oxi-
dative homeostasis can be considered as fundamental
mechanism of hormesis, implying adaptation to stress
upon exposure to mild stress, eventually resulting in in-
creased resistance to the more aggressive stress25. Thus,
the purpose of our study was to evaluate possible interac-
tions between different concentrations of lipid peroxida-
tion agents causing mild oxidative stress with novel
1,4-dihydropyridine derivatives, which might exert anti-
oxidant bioactivities.
We have used two lipid peroxidation mediators, CuSO4,
well known oxidizing agent26,27 and HNE, the end prod-
uct of lipid peroxidation product, which acts as signaling
and cell growth regulating factor3,5,7,8,15,28. Even CuSO4
may be considered to be effective due to the activity of
copper ions that induce lipid peroxidation resulting in
production of reactive aldehydes, such as HNE. In our
study we have used 3H-thymidine incorporation assay to
monitor effects of CuSO4 on cell proliferation due subtle
differences in cell growth caused by mild oxidative stress.
Addition of novel antioxidant compounds, CER and Z41-
74, under such conditions modulated cell proliferation.
The basis of the stimulating effects on cell proliferation
could lie in the interactions between copper, serum albu-
min and antioxidants, while according to our knowledge
none of the antioxidant substances tested is able to bind
and inactivate directly copper or HNE. It is certain how-
ever that higher doses of copper (>50 mM) cause oxida-
tion of serum with a delay, but also to a lesser degree
than lower doses due to presence of antioxidants in the
serum29. These interactions could result in cell adapta-
tion to mild oxidative stress consequentially increasing
tolerance to oxidative stress, i.e promoting hormesis.
That might be especially important for the cells and tis-
sues which have physiologically present high amounts of
HNE and for which HNE seems to play certain physio-
logical, not only pathological roles11,12,30,31. Taking into
account that lipid peroxidation end products, especially
HNE, affect signaling pathways relevant for the bone re-
generation, we have tested effects of HNE on growth of
HOS cells directly by adding HNE to HOS cells and indi-
rectly by causing lipid peroxidation with CuSO4 that is
followed by HNE formation26. To enhance HNE effects
as a cell growth modulator, we combined it with CER and
Z41-74, respectively.
Obtained results indicated that the growth stimulat-
ing concentrations of HNE (ranging from 1 to 10 mM)
could be enhanced either by CER or by Z41-74, indicat-
ing possible role of these compounds in modulation of cell
growth through modulation of redox signaling pathways.
Namely, HNE is a cell growth regulating factor, which af-
fects expression of several proto-oncogenes and inter-
feres with bioactivities of cytokines, such as TGF beta,
PDGF, FGF and EGF. The effects of HNE are therefore
very complex, but their concentration dependence in vi-
tro usually points to the growth stimulation if used at low
concentrations and suppression when supraphysiological
or toxic concentrations are used. Accordingly, we may as-
sume that the tested antioxidants interfere with the cel-
lular redox signaling and growth regulating effects of
HNE. Furthermore, our findings suggest differential in-
fluence of the tested substances in respect to the concen-
tration dependent bioactivities of HNE, which might fur-
ther open possibilities of the differential usage of the
tested substances and HNE for the treatment of differ-
ent cell types, such as malignant and non-malignant
counterpart cells aiming to modulate their growth in de-
sirable way.
This could be of particular importance for better un-
derstanding and control of bone cell growth since it was
previously shown that HOS cells are convenient model to
study not only cytotoxic but also growth modifying ef-
fects of lipid peroxidation11. Namely, HNE itself modu-
lates HOS cell growth by interaction with several cyto-
kines present in serum, especially EGF15. Also, HNE was
shown to display dose-dependent effect modulated by
binding to serum proteins. HNE-serum protein adducts
reduce interactions between HNE and cell membrane
thereby diminishing possible cytotoxic effects of HNE7,15.
Accordingly, CER and Z41-74 might affect growth regu-
lating effects of HNE by interfering with its affinity to
bind to humoral as well as to cellular proteins; however,
this assumption has to be further verified. Combining
the results of two complementary methods used in this
study, measuring cell proliferation and cell mitochon-
drial activity, it can be concluded that both of the tested
compounds, CER and Z41-74 acted as biological response
modifiers, modulating cell adaptation to mild oxidative
stress induced either by CuSO4 or by HNE.
These results might be relevant for human medicine,
especially in context of bone and damaged tissue healing
and should be further studied considering a possibility of
HNE involvement in signaling pathways of tissue regen-
eration.
Thus, our results showed that both CER and Z41-74
may be efficient in regulation of oxidative homeostasis
and might therefore support the hormesis signaling based
on HNE, which shall be further studied, especially in re-
spect to the possible differences in regulation of oxidative
homeostasis between malignant and non-malignant cells.
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MODULACIJA RASTA LJUDSKIH STANICA IN VITRO BLAGIM OKSIDACIJSKIM STRESOM I
ANTIOKSIDACIJSKIM DERIVATIMA 1,4-DIHIDROPIRIDINA
S A @ E T A K
Reaktivni kisikovi radikali i produkti lipidne peroksidacije osim citotoksi~nog u~inka mogu utjecati i na prijenos sig-
nala u stanici. Antioksidansi pak mogu biti modulatori biolo{kih aktivnosti koje su posljedica oksidacijskog stresa. Sto-
ga smo u ovom radu istra`ili ulogu dva antioksidansa, derivata 1,4-dihidropridina, nazvanih cerebrokrast ili Z41-74 na
in vitro rast humanih osteosarkomskih stanica, model humanih osteoblasta, osjetljivih na oksidacijski stres i lipidnu
peroksidaciju. Stanice su bile sat vremena izlo`ene trima razli~itim koncentracijama sintetskih antioksidansa, cerebro-
krasta ili Z41-74, nakon ~ega su izlo`ene niskim koncentracijama bakrenog sulfata ili 4-hidroksinonenala, krajnjeg
produkta lipidne peroksidacije. Oba antioksidansa pokazala su pozitivan u~inak na rast stanica. Naime, stanice pretho-
dno izlo`ene antioksidansima bolje su rasle i imale su pove}anu metaboli~ku aktivnost nego stanice koje su bile izlo`ene
samo oksidacijskom stresu. Ovaj biomodulacijski u~inak cerebrokrasta i Z41-74 podsje}a na biomodulacijske u~inke
4-hidroksinonenala, stoga mo`e biti posljedica stani~ne adaptacije na oksidacijski stres s obzirom da antioksidansi dje-
luju na redoks procese i signalne putove 4-hidroksinonenala. To bi moglo biti posebno zna~ajno za razumijevanje uloge
4-hidroksinonenala u cijeljenju tkiva. Dakle antioksidansi, cerebrokrast i Z41-74 bi mogli kontrolirati procese oksi-
dacijske homeostaze {to bi trebalo potvrditi daljnjim istra`ivanjima.
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